KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesSales of Property, Plant and EquipmentShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Jazz Pharmaceuticals (JAZZ) Gains from Investment Securities (2016 - 2025)

Jazz Pharmaceuticals (JAZZ) has 16 years of Gains from Investment Securities data on record, last reported at $80.3 million in Q3 2025.

  • For Q3 2025, Gains from Investment Securities rose 1987.54% year-over-year to $80.3 million; the TTM value through Sep 2025 reached $77.1 million, down 68.11%, while the annual FY2023 figure was $177.9 million, 291.44% up from the prior year.
  • Gains from Investment Securities reached $80.3 million in Q3 2025 per JAZZ's latest filing, up from -$7.8 million in the prior quarter.
  • Across five years, Gains from Investment Securities topped out at $232.1 million in Q4 2023 and bottomed at -$67.2 million in Q3 2023.
  • Average Gains from Investment Securities over 5 years is $16.4 million, with a median of $2.9 million recorded in 2021.
  • Peak YoY movement for Gains from Investment Securities: crashed 2348.78% in 2023, then surged 1987.54% in 2025.
  • A 5-year view of Gains from Investment Securities shows it stood at -$39.6 million in 2021, then surged by 148.17% to $19.1 million in 2022, then surged by 1115.98% to $232.1 million in 2023, then plummeted by 98.34% to $3.8 million in 2024, then soared by 1987.54% to $80.3 million in 2025.
  • Per Business Quant database, its latest 3 readings for Gains from Investment Securities were $80.3 million in Q3 2025, -$7.8 million in Q2 2025, and $752000.0 in Q1 2025.